What is LOPJLB’s current signal on PRQR?

LOPJLB’s latest quantitative signal on ProQR Therapeutics N.V. (PRQR) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is PRQR in?

ProQR Therapeutics N.V. (PRQR) is currently classified in the CRISIS HMM market regime on LOPJLB.

Where is ProQR Therapeutics N.V. based / listed?

ProQR Therapeutics N.V. is based in NL, listed on NASDAQ.

ProQR Therapeutics N.V. (PRQR)

COMPARE

Healthcare · Biotechnology · NASDAQ · NL

$1.63+3.82%Close

SELLCRISIS · day 20

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $172M
Beta: 0.03
P/E (TTM): -3.70

Short % float: 4.46%
Days to cover: 5.0
SI change: +19.2%

1W: -0.61%
1M: -15.98%

vs SPY 1W: -1.77%
vs SPY 1M: -18.97%

Industry peers

FMP comparable companies · ranked by market cap

ACHVSELLAchieve Life Sciences, Inc.$738MBEARQ -10$7.19+3.06%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

ProQR Therapeutics N.V. operates as a biopharmaceutical enterprise dedicated to discovering and developing RNA-based therapies designed to address genetic disorders. The company's pipeline includes two primary drug candidates in advanced clinical stages: Sepofarsen is currently…

Employees: 166
Headquarters: NL
Founded: 2014
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 105.3M
Float: 61.1%

proqr.com ↗

Key executives

Daniel Anton de Boer — Founder, CEO & Executive Director

Gerard Platenburg — Co-Founder, Chief Scientific Officer & Executive Director

Cristina Lopez Lopez — Chief Medical Officer

SEC filings

EDGAR · CIK 16129400 · PRQR

Analyst consensus

Buy

Bullish1191.7%

Neutral18.3%

Bearish00.0%

L $3.00Avg $3.00H $3.00

Target$3.00+84.05%

Last$1.63

Key stats

Industry peers

Prediction markets

Company news